Cryptogenic organizing pneumonitis: Difference between revisions

Jump to navigation Jump to search
Michael Maddaleni (talk | contribs)
Michael Maddaleni (talk | contribs)
No edit summary
Line 17: Line 17:
{{SK}} Bronchiolitis obliterans organizing pneumonia; BOOP; COP
{{SK}} Bronchiolitis obliterans organizing pneumonia; BOOP; COP


==Overview==
==[[Cryptogenic organizing pneumonitis overview|Overview]]==


==Epidemiology==
==[[Cryptogenic organizing pneumonitis historical perspective|Historical Perspective]]==


==Etiology==
==[[Cryptogenic organizing pneumonitis pathophysiology|Pathophysiology]]==
 
==[[Cryptogenic organizing pneumonitis causes|Causes]]==
 
==[[Cryptogenic organizing pneumonitis differential diagnosis|Differentiating Cryptogenic organizing pneumonitis from other Diseases]]==
 
==[[Cryptogenic organizing pneumonitis epidemiology and demographics|Epidemiology and Demographics]]==
 
==[[Cryptogenic organizing pneumonitis risk factors|Risk Factors]]==
 
==[[Cryptogenic organizing pneumonitis screening|Screening]]==
 
==[[Cryptogenic organizing pneumonitis natural history|Natural History, Complications and Prognosis]]==


==Diagnosis==
==Diagnosis==
[[Cryptogenic organizing pneumonitis history and symptoms|History and Symptoms]] | [[Cryptogenic organizing pneumonitis physical examination|Physical Examination]] | [[Cryptogenic organizing pneumonitis laboratory tests|Laboratory Findings]] | [[Cryptogenic organizing pneumonitis chest x ray|Chest X Ray]] | [[Cryptogenic organizing pneumonitis CT|CT]] | [[Cryptogenic organizing pneumonitis MRI|MRI]] | [[Cryptogenic organizing pneumonitis other imaging findings|Other Imaging Findings]] | [[Cryptogenic organizing pneumonitis other diagnostic studies|Other Diagnostic Studies]]


==Treatment==
==Treatment==
[[Cryptogenic organizing pneumonitis medical therapy|Medical Therapy]] | [[Cryptogenic organizing pneumonitis surgery|Surgery]] | [[Cryptogenic organizing pneumonitis primary prevention|Primary Prevention]]  | [[Cryptogenic organizing pneumonitis secondary prevention|Secondary Prevention]] | [[Cryptogenic organizing pneumonitis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Cryptogenic organizing pneumonitis future or investigational therapies|Future or Investigational Therapies]]
==Case Studies==
[[Cryptogenic organizing pneumonitis case study one|Case #1]]





Revision as of 14:58, 24 September 2012